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2 Nanomaterials integrated with different therapeutic and diagnostic functional agents have attracted considerable attention in recent years due to their great potential in precision medicine. [1] To date, large quantities of theranostic agents for simultaneous use in different imaging and therapeutic technologies, such as magnetic resonance imaging -photothermal therapy (MRI-PTT), [2] optical imaging -photodynamic therapy (PDT), [3] MRIchemotherapy, [4] computed tomography (CT)-PTT, [5] and photoacoustic imaging (PAI)-PTT, [6] were fabricated from individual functional agents, which could be detached from each other during circulation and metabolism in vivo, leading to different biodistributions and pharmacokinetics, inaccurate diagnosis, and poor therapy efficacy. Therefore, it is important to develop theranostic platforms based on single material which can serve as both imaging agent and therapeutic agent. [7] Near-infrared (NIR) absorbing materials have strong absorption in the region of 700-3000
nm. An advantage of this type of material is their capability of converting the NIR light, which can penetrate into deep tissues, into heat for photoacoustic imaging (PAI) and thermal ablation of malignant tumors. [5] [6] 8] PAI shows distinct advantages over the traditional optical imaging, including low signal scattering in tissues, and high resolution and sensitivity.
Photothermal therapy (PTT) is a promising noninvasive alternative to traditional cancer therapies, which has attracted considerable interest in recent years due to its highly specific selectivity towards the targeted sites. The combination of PTT and PAI could provide a perfect solution for accurate diagnosis and treatment of cancer, because they could both use the same NIR absorbing material as theranostic agent without any need to consider detachment of different functional units after intravenous administration.
The currently available NIR-absorbing materials include NIR dyes, [9] gold nanomaterials, [10] carbon nanomaterials, [6, 11] upconversion nanoparticles, [12] transition-metal dichalcogenides, [13] and some organic polymers. [14] In comparison with small molecular NIR dyes, NIR absorbing nanomaterials with proper surface modification exhibit longer blood 3 circulation time for tumor targeting. In addition, due to the enhanced permeability and retention (EPR) effect, nanomaterials also have longer retention time in tumor sites than small molecules, and provide a much longer time window for tumor diagnosis and therapy.
Nevertheless, most exogenous nanomaterials are easily taken up by the reticuloendothelial system (RES), e.g., liver and spleen, which could cause potential risks of toxicity due to long retention time if they are difficult to degrade and metabolize in vivo. Therefore, the development of nanotheranostic agents that are subject to fast metabolism in normal organs and tissues, but have long retention time in tumors is of great importance for their practical applications.
Herein, we report a novel PAI-PTT theranostic agent based on pH-sensitive Fe(III)-gallicacid nanoparticles with strong NIR absorbance, which can be easily decomposed under neutral conditions, but remain stable under acidic conditions. Due to the weak acidic condition in tumors, which is different from that in normal tissue, our Fe(III)-gallic-acid nanoparticles could be retained in tumor sites, while being easily decomposed and metabolized in other organs, leading to excellent in-vivo photoacoustic imaging and a good photothermal therapy effect against tumors in mice.
It is well known that transition metal ions generally have incompletely filled d orbitals. absorption from 400 to 900 nm, with a peak centered at 575 nm.
The as-prepared complex solution exhibits strong pH-dependent stability. It is very stable when the solution pH is above 5.0, and no precipitates or particles were detected after one week by dynamic light scattering (DLS) measurements. When the pH is lower than 5.0, the complex can gradually aggregate and form nanoparticles, as shown in Figure 1b and Figure   S1 in the Supporting Information. The hydrodynamic size reaches up to ~45 nm within 72 h at pH 4.5. Decreasing the solution pH from 4.5 to 3.7 leads to fast aggregation and formation of nanoparticles, and their hydrodynamic size reaches ~45 nm within 2 h. The strong pHdependent stability is closely related to the protonation/deprotonation of carboxyl groups (-COOH) in gallic acid. As the acid dissociation constant (pKa) of -COOH in gallic acid is around 4.5, the electrostatic repulsion induced by deprotonation of -COOH can effectively prevent the aggregation of the Fe(III)-gallic-acid complex. When the pH is lower than or equal to the pKa, however, the electrostatic repulsion decreases significantly, and the hydrophobic interactions among the complex molecules lead to the formation of Fe(III)-gallic-acid nanoparticles. It is worth noting that the aggregation and formation of Fe(III)-gallic-acid nanoparticles is reversible. Figure 1c shows (Figure 1d and 1e), which is consistent with their hydrodynamic size of 45 nm ( Figure 1f ). Due to the strong NIR absorption, the Fe(III)-gallic-acid nanoparticles show obvious photoacoustic and photothermal effects. As shown in Figure 1g , the photoacoustic signal increases with increasing iron concentration from 0.05 mM to 1.0 mM, indicating that the Fe(III)-gallic-acid nanoparticles would be good candidates for PAI.
To evaluate their photothermal performance, Fe(III)-gallic-acid nanoparticles with various concentrations from 0.1 mM to 1.5 mM were exposed to an 808-nm NIR laser with a power density of 0.5 W/cm 2 . The temperature of each solution was recorded for 10 min under continuous laser irradiation until the solution reached a steady temperature. As shown in Figure 1h and Figure S2 , the temperature difference (T) drastically increases with the increasing particle concentration. The temperature of the Fe(III)-gallic-acid nanoparticle solution with a concentration of 1.5 mM can increase by 53 C after irradiation for 10 min.
The temperature of pure water was only increased by 2 C under the same conditions. In addition, their photothermal performance remains rather stable after five cycles of NIR laser irradiation (808-nm laser at 0.5 W/cm 2 , 10 min for each cycle) as shown in Figure 1i .
Furthermore, the photothermal conversion efficiency of Fe(III)-gallic-acid nanoparticles was 6 calculated to be 66.8% ( Figure S3 ), which is relatively high compared with those reported for NIR dyes, [16] gold nanomaterials, [7b, 15] carbon nanomaterials, [17] transition-metal dichalcogenides, [2c, 8d, 18] and polymer nanoparticles. [14a, 19] These results suggest that Fe(III)-gallic-acid nanoparticles would be an effective photothermal agent for cancer therapy, as cancer cells can be killed by being kept at 50 C for several minutes.
Considering the excellent photothermal performance of Fe ( [ 8b, 20] As photoacoustic imaging can also serve as a non-invasive imaging technique for semiquantifying the pharmacokinetics of drugs, we conducted a preliminary evaluation of the pharmacokinetics of Fe(III)-gallic-acid nanoparticles in mice by using the PAI method. Figure   4a displays the PA images of major organs of nude mice before and after injection of Fe(III)-gallic-acid nanoparticles. The PA signals of each organ were calculated and are presented in spleen. This is expected, as nanoparticles are easily captured by the reticuloendothelial system, leading to the strong PA signal. The PA signals of the liver and spleen reached an approximate plateau after 2 h, and then gradually decreased from 4 h and 6 h, respectively. After 24 h, the PA signal of the liver and spleen recovered to the pre-injection level, indicating that the Fe(III)-gallic-acid nanoparticles in these organs may be gradually decomposed into small molecular complexes and then easily excreted from the treated animals. In remarkable contrast, the Fe(III)-gallic-acid nanoparticles were still accumulating in the tumor after 24 h post-injection, as shown in Figure 3 .
The above results fully demonstrate that Fe(III)-gallicacid nanoparticles can be easily decomposed in the liver and spleen while remaining stable in the tumor with a long retention time. In addition, the clearance of Fe(III)-gallic-acid nanoparticles in vivo takes place more quickly than for other nanomaterials studied in the literature, [8a, 21] demonstrating that Fe(III)-gallic-acid nanoparticles could be a safe, promising candidate as a PAI-PTT theranostic agent.
To assess the in-vivo therapeutic potential of Fe(III)-gallic-acid nanoparticles, a further careful investigation of their photothermal therapeutic efficacy was carried out. Balb/c mice with subcutaneous 4T1 tumors were selected as the animal model. After the tumor sizes reached approximately 150 mm 3 , the mice were divided into four groups with 5 mice per group. For the treatment group, they were intravenously injected with Fe(III)-gallic-acid nanoparticles (4 mM, 200 μL for each mouse). After 8 h, their tumors were irradiated by an 808-nm laser for 10 min with a power density of 1 W/cm 2 . The other three groups included the saline injection group, a group in which the mice were injected with saline and also exposed to the laser, and a group in which the mice were injected with Fe(III)-gallic-acid nanoparticles, but without laser irradiation. The tumor sizes were measured every day after treatment. For the treatment group, the tumor shrank remarkably after 1 day of photothermal treatment, and black scars were formed, which were completely eradicated 14 days after treatment ( Figure 5a ). In contrast, for the other three control groups, neither the laser irradiation with the current power density nor Fe(III)-gallic-acid nanoparticles alone could affect the tumor growth (Figure 5b ). In addition, the mice in the control groups had an average lifespan of 30−33 days, shorter than for the treated mice, which were tumor-free after treatment and sacrificed on purpose after living for 45 days (Figure 5c Histological Analysis. For hematoxylin and eosin (H&E) staining, major organs, including the liver, spleen, kidney, heart, and lung, were harvested, fixed in 10% neutral buffered formalin, processed routinely into paraffin, sectioned into thin slices, and stained withH&E for histological analysis.
Supplementary Results

DLS analysis of Fe(III)-gallic-acid nanoparticles. Dynamic light scattering (DLS)
analysis was carried out to monitor the hydrodynamic size evolution of Fe(III)-gallic-acid nanoparticles formed under different pH. Figure S1a and S1b show the hydrodynamic size profiles of nanoparticles formed at pH 3.7 and 4.5, respectively. The results suggest that 
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Calculation of the photothermal conversion efficiency. Under the room temperature of 25 C, 0.5 mM Fe(III)-gallic-acid nanoparticles solution was loaded into a cuvette and irradiated using a 808-nm laser, followed by natural cooling after laser light was turned off.
The temperature profile monitored is shown in Figure S3a . The photothermal conversion efficiency is calculated according to the following equation. [1] The photothermal conversion efficiency  can be given as where m is the solution mass and equal to 1.0 g in the current study, c is the heat capacity of water and equal to 4.2 J/g, T max and T max,water are the maximum temperature change for nanopaticles solution and water, which are 21.2 C and 1.4 C, respectively, I is the laser power and equal to 0.5 W in the current study, A is the absorbance of nanoparticles solution at 808 nm and equal to 0.4294,  s is the system time constant and equal to 396.4 s according to the linear regression of the cooling profile ( Figure S3b ). The photothermal conversion efficiency is calculated to be 66.8% by using these parameters. Figure S3 . (a) The temperature profile of a 0.5 mM Fe(III)-gallic-acid nanoparticles solution irradiated with a 808-nm laser, followed by natural cooling after laser was turned off. (b) Determination of the system time constant using linear regression of the cooling profile shown in (a). Figure S4 shows the hydrodynamic size evolution of Fe(III)-gallic-acid nanoparticles incubated in pH 7.0 aqueous medium and 10% FBS with different pH values. Fe(III)-gallic-acid nanoparticles show a slower degradation in 10% FBS (pH = 7) than in neutral water. If Fe(III)-gallic-acid nanoparticles were incubated in weak acidic 10% FBS (pH 5.0 and 5.6), they remained stable in 6 h but precipitated after 24 h. Figure S4 . Evolution of hydrodynamic size of Fe(III)-gallic-acid nanoparticles incubated in pH 7.0 aqueous media and 10% FBS with different pH values.
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DLS analyses of Fe(III)-gallic-acid nanoaprticles in 10% FBS.
